GlassScriptPhysician profile
Joyce W Wald
NPI 1275522120
$96,902.02
in general payments reported to CMS, 2019-2025
19 companies · $22K in 2025
The $22K reported for 2025 was more than what 85% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,534 · 2020: $743 · 2021: $7,865 · 2022: $24K · 2023: $19K · 2024: $23K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $29K · Consulting Fee: $15K · Food and Beverage: $11K · Travel and Lodging: $4,899 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $28,900.00 |
| Consulting Fee | $15,100.00 |
| Food and Beverage | $10,739.35 |
| Travel and Lodging | $4,899.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,588.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $30,100.11 | 2020-2025 | Impella |
| Impulse Dynamics (USA) INC. | $24,291.67 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $21,685.66 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, 2nd Gen Centrimag Primary Console |
| Boston Scientific Corporation | $12,788.29 | 2021-2025 | General - Structural Heart, Watchman Flx, General - Therapies |
| Medtronic, INC. | $4,755.08 | 2021-2023 | |
| Medtronic Vascular, INC. | $1,014.11 | 2019-2020 | |
| Cvrx, INC. | $746.17 | 2023-2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $457.41 | 2022-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $421.29 | 2020-2024 | |
| Daxor Corporation | $127.64 | 2024 | Bva-100 |
| Paragonix Technologies, INC. | $120.88 | 2025 | Sherpapak |
| Merck Sharp & Dohme LLC | $115.60 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.41 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $69.61 | 2025 | |
| Amgen INC. | $67.64 | 2024-2025 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $32.57 | 2025 | Extended Holter |
| Novo Nordisk INC | $16.39 | 2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $15.49 | 2024 | Jardiance |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Wald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.